Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

GSK’s vaccines head Moncef Slaoui will retire next year

He will continue as a director until March and an advisor until June 2017

How good are your digital sales materials? Just ask these 5 questions

Might your sales materials be stuck on step one of the digital technology journey? Consider these five questions to get your answer:

Anthill Agency

- PMLiVE

Updated EMPA-REG data show Jardiance also protects kidney

Boehringer Ingelheim and Lilly’s drug is the first to show positive impact on kidney damage

- PMLiVE

Developing Medical Education That Advances Patient Outcomes

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in...

Lucid Group Communications Limited

- PMLiVE

AZ’s Gabriel Baertschi joins Grünenthal as CEO

He also becomes chairman of the corporate executive board

- PMLiVE

Sue Neilen moves to Virgo Health from Langland

She becomes head of communications

Biosimilars – the Brexit of the pharmaceutical industry?

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities...

Blue Latitude Health

- PMLiVE

Victoza cuts cardiovascular risk in landmark study

Novo Nordisk’s diabetes therapy outcomes ‘beyond expectations’

- PMLiVE

Teva suspends migraine patch on burn reports

FDA issues safety alert and instigates investigation into Zecuity

- PMLiVE

miRagen Therapeutics bolsters senior leadership team

Adam Levy and Christopher Mori take on new roles

- PMLiVE

Red Door Unlimited appoints head of social

Antia Buhigas joins the agency’s leadership team

- PMLiVE

Technology: the missing link in true patient engagement?

Approximately 50% of patients do not take their medication as prescribed. This comes at a huge financial cost, and results in suboptimal patient outcomes. There is a wealth of research...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links